Citation

Magalotti SR, Neudecker M, Zaraa SG, McVoy MK. Curr. Psychiatry Rep. 2019; 21(12): e123.

Affiliation

W. O. Walker Building, Division of Child and Adolescent Psychiatry, 10524 Euclid Ave, Suite 1155A, Cleveland, OH, USA. molly.mcvoy@uhhospitals.org.

Copyright

(Copyright © 2019, Holtzbrinck Springer Nature Publishing Group)

DOI

10.1007/s11920-019-1105-1

PMID

31741142

Abstract

PURPOSE OF REVIEW: Youth aggression is common and has a significant burden on individuals, families, and society. However, its treatment is often a challenge for clinicians. Thus, this review will examine the current understanding of youth aggression, conceptualize aggression as a symptom rather than its own disorder, and provide an overview of treatment strategies. RECENT FINDINGS: Youth aggression is associated with complex genetic, neurobiological, and environmental risks. Prevention strategies are of the utmost importance for at-risk families and youth. Psychosocial interventions are the first line treatment. But if not fully effective, then pharmacologic interventions-including psychostimulants, alpha-2 agonists, atomoxetine, and risperidone-have shown benefits. Other medications, such as SSRIs, can be useful in certain scenarios. It is important to conceptualize youth aggression as being a trans-diagnostic symptom in psychopathology. Determining the underlying cause of aggression will help to guide treatment.

Language: en

Keywords

ADHD; Aggression; Antipsychotic; Conduct; ODD; Pediatric; Stimulant; Treatment